The Global Hemostatic Gels Industry, which boasted a remarkable valuation of US$957.1 million in 2021, is on track for an extraordinary journey, poised to reach a staggering US$1.9 billion by 2032. This optimistic trajectory is propelled by a robust Compound Annual Growth Rate (CAGR) of 6.8%, according to a comprehensive analysis conducted by Future Market …